Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - Kistos Holdings plc (AIM:KIST) announced Monday that shareholders approved all resolutions put forward at its Annual General Meeting (AGM).
The company reported that 14 resolutions were passed by the required majority at the meeting held on June 30, 2025. Resolutions 1 through 11 were passed as ordinary resolutions, while resolutions 12 through 14 were passed as special resolutions.
Among the key approvals, shareholders voted to re-elect all board members, including Andrew Austin, Richard Benmore, Alan Booth, Peter Mann, and Stephen Pawson. James Thomson was elected as a new director, with 99.96% of votes cast in favor.
Shareholders also approved the company’s 2024 Annual Report, the Directors’ Remuneration Report, and the Directors’ Remuneration Policy. BDO LLP was re-appointed as the company’s auditor.
Notable special resolutions that received approval included the disapplication of pre-emption rights, authority to buy back up to 25% of the company’s issued share capital, and the Capital Reduction Bonus Issue and Capital Reduction.
The poll results showed strong support for all resolutions, with approval ratings ranging from 99.80% to 99.96%.
Kistos Holdings, which trades on London’s AIM market under the ticker KIST, reported that the total number of shares in issue at the voting date was 82,863,743.
This information is based on a press release statement issued by the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.